Cancer Research SA

Adelaide 5000

8 studies enrolling now · 12 studies all time

What they study most

Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic Non-small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Cancer, Endometrial Neoplasms, Fallopian Tube Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Metastatic Head and Neck Cancer

Studies at this site

• A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors — Recruiting now
• A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer — Recruiting now
• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer — Recruiting now
• A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors — Recruiting now
• A Study of LY4170156 in Participants With Selected Advanced Solid Tumors — Recruiting now
• Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors — Recruiting now
• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) — Running, not enrolling
• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early